FGEN

FibroGen Stock Price

20.705
-0.355 (-1.69%)
Upgrade to Real-Time
Regular Market
20.705

Low
18.12

52 Week Range

High
57.2088

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.355 -1.69% 20.705 10:01:25
Open Price Low Price High Price Close Price Prev Close
21.04 20.5143 21.04 21.06
Bid Price Ask Price Spread News
20.69 20.72 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
670 69,168 $ 20.84 $ 1,441,350 875,182 18.12 - 57.2088
Last Trade Time Type Quantity Stock Price Currency
10:01:25 100 $ 20.705 USD

FibroGen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.88B 91.01M 79.57M $ 256.58M $ - -0.96 -18.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

FibroGen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.3821.0618.7719.922,233,7871.336.84%
1 Month31.1536.12518.1221.383,052,310-10.45-33.53%
3 Months49.8657.208818.1229.301,665,414-29.16-58.47%
6 Months45.3957.208818.1233.351,190,898-24.69-54.38%
1 Year38.0757.208818.1236.15929,698-17.37-45.61%
3 Years46.6068.5518.1241.39724,063-25.90-55.57%
5 Years20.4968.5514.5039.58642,8920.2151.05%

FibroGen Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.


Your Recent History
NASDAQ
FGEN
FibroGen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.